New antiplatelet and anticoagulant drugs.

Wynn, Richard L

Wynn, Richard L.

Affiliation

Wynn RL; Department of Oral Craniofacial Biological Sciences, Dental School, University of Maryland at Baltimore, USA.

Gen Dent ; 60(1): 8-11, 2012.

Article in En | MEDLINE | ID: mdl-22313973

Subject(s)

Anticoagulants/therapeutic use; Platelet Aggregation Inhibitors/therapeutic use; Anticoagulants/adverse effects; Antithrombins/adverse effects; Antithrombins/therapeutic use; Benzimidazoles/adverse effects; Benzimidazoles/therapeutic use; Clinical Trials as Topic; Dabigatran; Dental Care for Chronically Ill; Factor Xa Inhibitors; Humans; Morpholines/adverse effects; Morpholines/therapeutic use; Oral Hemorrhage/prevention & control; Piperazines/adverse effects; Piperazines/therapeutic use; Platelet Aggregation Inhibitors/adverse effects; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists/adverse effects; Purinergic P2Y Receptor Antagonists/therapeutic use; Rivaroxaban; Thiophenes/adverse effects; Thiophenes/therapeutic use; beta-Alanine/adverse effects; beta-Alanine/analogs & derivatives; beta-Alanine/therapeutic use

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Platelet Aggregation Inhibitors / Anticoagulants Limits: Humans Language: En Journal: Gen Dent Year: 2012 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links